主页 文献库文献详情
PMID: 25862976 已发表 · ppublish 英语

Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer.

Cancer letters ·第 362 卷 ·第 2 期 ·2015-06-26

Kreuzinger Caroline, Gamperl Magdalena, Wolf Andrea, Heinze Georg, Geroldinger Angelika, Lambrechts Diether, Boeckx Bram, Smeets Dominiek, Horvat Reinhard, Aust Stefanie, Hamilton Gerhard, Zeillinger Robert, Cacsire Castillo-Tong Dan

摘要

Cancer cell lines are good in vitro models to study molecular mechanisms underlying chemoresistance and cancer recurrence. Recent works have demonstrated that most of the available ovarian cancer cell lines are most unlikely high grade serous (HGSOC), the major type of epithelial ovarian cancer. We aimed at establishing well characterized HGSOC cell lines, which can be used as optimal models for ovarian cancer research. We successfully established seven cell lines from HGSOC and provided the major genomic alterations and the transcriptomic landscapes of them. They exhibited different gene expression patterns in the key pathways involved in cancer resistance. Each cell line harbored a unique TP53 mutation as their corresponding tumors and expressed cytokeratins 8/18/19 and EpCAM. Two matched lines were established from the same patient, one at diagnosis and being sensitive to carboplatin and the other during chemotherapy and being resistant. Two cell lines presented respective BRCA1 and BRCA2 mutations. To conclude, we have established seven cell lines and well characterized them at genomic and transcriptomic levels. They are optimal models to investigate the molecular mechanisms underlying the progression, chemo resistance and recurrence of HGSOC.

关键词
BRCA Cell line High grade serous ovarian cancer Platinum TP53
文献信息
期刊
Cancer letters
期刊简称
Cancer Lett
发表日期
2015-06-26
收录日期
2015-04-27
更新日期
2015-04-27
语言
英语
国家/地区
Ireland
NLM ID
7600053
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com